Selenoproteins and their emerging roles in signaling pathways by Stanishevska, N.V.
 
Regul. Mech. Biosyst., 2020, 11(2) 
 
Regulatory Mechanisms  
in Biosystems  
ISSN 2519-8521 (Print)  
ISSN 2520-2588 (Online) 
Regul. Mech. Biosyst.,  
2020, 11(2), 186–199 
doi: 10.15421/022028 
Selenoproteins and their emerging roles in signaling pathways  
N. V. Stanishevska  
Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine, Dnipro, Ukraine  
Article info 
Received   24.03.2020 
Received in revised form 
20.04.2020 
Accepted   23.04.2020 
 
Dnipropetrovsk  
Medical Academy,  
Sevastopolska st. 19,  
Dnipro, 49000, Ukraine.  
Tel.: +38-067-282-04 -05.  
E-mail:  
natstanishevska3536@ 
gmail.com 
Stanishevska, N. V. (2020). Selenoproteins and their emerging roles in signaling pathways. Regulatory Mechanisms in Biosys-
tems, 11(2), 186–199. doi:10.15421/022028  
The functional activity of selenoproteins has a wide range of effects on complex pathogenetic processes, including teratogenesis, 
immuno-inflammatory, neurodegenerative. Being active participants and promoters of many signaling pathways, selenoproteins 
support the lively interest of a wide scientific community. This review is devoted to the analysis of recent data describing the partici-
pation of selenoproteins in various molecular interactions mediating important signaling pathways. Data processing was carried out 
by the method of complex analysis. For convenience, all selenoproteins were divided into groups depending on their location and 
function. Among the group of selenoproteins of the ER membrane, selenoprotein N affects the absorption of Ca2+ by the endoplas-
mic reticulum mediated by oxidoreductin (ERO1), a key player in the CHOP/ERO1 branch, a pathogenic mechanism that causes 
myopathy. Another selenoprotein of the ER membrane  selenoprotein K binding to the DHHC6 protein affects the IP3R receptor that 
regulates Ca2+ flux. Selenoprotein K is able to affect another protein of the endoplasmic reticulum CHERP, also appearing in Ca2+ 
transport. Selenoprotein S, associated with the lumen of ER, is able to influence the VCP protein, which ensures the incorporation of 
selenoprotein K into the ER membrane. Selenoprotein M, as an ER lumen protein, affects the phosphorylation of STAT3 by leptin, 
which confirms that Sel M is a positive regulator of leptin signaling. Selenoprotein S also related to luminal selenoproteins ER is a 
modulator of the IRE1α-sXBP1 signaling pathway. Nuclear selenoprotein H will directly affect the suppressor of malignant tumours, 
p53 protein, the activation of which increases with Sel H deficiency. The same selenoprotein is involved in redox regulation. Among 
the cytoplasmic selenoproteins, abundant investigations are devoted to SelP, which affects the PI3K/Akt/Erk signaling pathway 
during ischemia/reperfusion, is transported into the myoblasts through the plasmalemma after binding to the apoER2 receptor, and 
into the neurons to the megaline receptor and in general, selenoprotein P plays the role of a pool that stores the necessary trace ele-
ment and releases it, if necessary, for vital selenoproteins. The thioredoxin reductase family plays a key role in the invasion and me-
tastasis of salivary adenoid cystic carcinoma through the influence on the TGF-β-Akt/GSK-3β pathway during epithelial-
mesenchymal transition. The deletion of thioredoxin reductase 1 affects the levels of messengers of the Wnt/β-catenin signaling 
pathway. No less studied is the glutathione peroxidase group, of which GPX3 is able to inhibit signaling in the Wnt/β-catenin path-
way and thereby inhibit thyroid metastasis, as well as suppress protein levels in the PI3K/Akt/c-fos pathway. A key observation is 
that in cases of carcinogenesis, a decrease in GPX3 and its hypermethylation are almost always found. Among deiodinases, deiodi-
nase 3 acts as a promoter of the oncogenes BRAF, MEK or p38, while stimulating a decrease in the expression of cyclin D1. 
The dependence of the level of deiodinase 3 on the Hedgehog (SHH) signaling pathway is also noted. Methionine sulfoxide reduc-
tase A can compete for the uptake of ubiquitin, reduce p38, JNK and ERK promoters of the MAPK signaling pathway; methionine 
sulfoxide reductase B1 suppresses MAPK signaling messengers, and also increases PARP and caspase 3.  
Keywords: functions of selenoproteins; cytoplasm selenoproteins; thioredoxin reductases; glutathione peroxidases; methionine 
sulfoxide reductases; carcinogenesis.  
Introduction  
 
To date, a cluster of selenoproteins, including 25 species, is being 
actively studied due to the involvement of these compounds in a num-
ber of important biomolecular mechanisms that affect pathogenetic pro-
cesses such as carcinogenesis, oxidative stress, inflammation, and neu-
rodegeneration.  
So, the search for ways to influence the expression of selenoprote-
ins with the aim of controlling some teratogenic processes is currently 
underway. One of these is an attempt to inactivate the UGA gene and 
tRNA, which encode and translate accordingly the selenocysteine resi-
due, which is part of all selenoproteins. A number of authors have found 
that Cas9-sgRNA ribonucleoproteins using the CRISPR technique can 
induce efficient genome editing in Hek293, HepG2, HaCaT, HAP1, 
HeLa, and LNCaP cell cultures, which causes a strong decrease in the 
expression of selenoproteins (Vindry et al., 2019). Attempts to study the 
basics of controlling selenoprotein regulators are carried out not only 
through gene modifications, but also by determining the role of gene 
polymorphism. A number of works are devoted to the study of the 
relationship of genes polymorphisms encoding certain selenoproteins 
with risks and predictions in the development of tumors. The clinic 
studied the polymorphism of the gene of selenoprotein (Sep15), which 
is a selenocysteine-containing oxidoreductase, in women with breast 
cancer. Clinical and pathological parameters such as age, stage of dise-
ase, tumour type, classification and receptor status did not reveal a con-
nection with polymorphism for this gene. Selenoprotein gene polymor-
phism (Sep15) did not affect the risk of breast cancer. (Watrowski et al., 
2016). However, in the case of diabetes, it was found that genetic poly-
morphism for selenoprotein S is associated with type 2 diabetes (Zhao 
et al., 2018).  
A number of promoters are involved in the mechanism of seleno-
proteins expression regulation, through the action of which selenoprote-
in activity can also be controlled. Thus, in the model of the C28/I2 
chondrocyte cell line, sufficient expression of SBP2 (selenocysteine 
binding protein) and miR-181a-5p (one of the post-transcriptional gene 
expression regulators) was detected under conditions of normal Se con-
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tent and vice versa, insufficient expression was revealed in case of Se 
deficiency. miR-181a-5p regulates SBP2 in the chondrocyte model. It is 
miR-181a-5p that is more sensitive to Se deficiency. Thus, a mechan-
ism for reducing the expression of selenoproteins through the effect on 
selenocysteine-binding protein and miR-181a-5p was revealed (Min 
et al., 2018).  
The existence of selenoproteins also depends on another promoter, 
which has caused interest due its influence on the signaling pathway 
that regulates the proliferative and migratory abilities of cells. The bio-
synthesis of selenocysteine included in selenoproteins is regulated by 
the Trnau1ap protein, the deficiency of which inhibits the proliferation 
of cardiomyocyte-like cells. On the model of NIH3T3, JEG-3, and 
Bewo cells (embryonic, trophoblastic, and placental, respectively), a 
decrease in the expression of selenoproteins determines upon knock-
down of the Trnau1ap protein. Along with this, a decrease in the prolife-
ration and migration of cells of these groups is noted. Inhibition of Akt 
phosphorylation (a member of the protein kinase family, a key player of 
the PI3K/Akt signaling pathway) in the PI3K/Akt signaling pathway is 
observed. Thus, the Trnau1ap protein modulates the PI3K/Akt signaling 
pathway and simultaneously affects the expression of selenoproteins, 
thereby playing an important role in the regulation of cell proliferation 
and migration in embryogenesis (Hu et al., 2018).  
In addition to the above regulatory proteins for the synthesis of se-
lenoproteins, the catalytic activity of selenoproteins depends on the in-
corporation of the selenocysteine residue. This function is performed by 
the protein binding (SECISBP2) in parallel affecting the signaling path-
way PI3K/Akt and ERK. The authors clarified the role of this protein in 
trophoblast cells and the molecular mechanism that ensures its function. 
Turning off SECISBP2 by miRNA transfection reduced levels of only 
some selenoproteins – GPx1, SelK, Dio2, while MDA (malondialde-
hyde) levels increased. SECISBP2 silence suppressed the proliferation, 
migration and invasion of trophoblast cells; significantly reduced the 
level of β-hCG (β chorionic gonadotropin) and progesterone. Inactiva-
tion of the PI3K/Akt and ERK signaling pathways has also been de-
tected (Li et al., 2017).  
The participation of selenoproteins in many pathogenetic processes 
creates an interest in studying the mechanisms and key players in the 
signaling pathways that mediate this participation with the goal of fur-
ther therapeutic effects. It has particular importance in the case of tera-
togenesis. For example the expression of selenoprotein M increases and 
correlates with late stage, progression and short survival in patients with 
renal cell carcinoma. In a mouse experiment, deletion of this seleno-
protein reduces viability, clonality, and metastasis of renal cancer cells 
and suppresses tumour growth (Jiang et al., 2019).  
Recently, overexpression of M selenoproteins M (SELM) has also 
been detected in human hepatocellular carcinoma cells. An increase of 
SELM expression in the liver tissue of hepatocellular carcinoma and a 
gradual increase in expression are associated with an increase in the 
level of malignancy. The authors suggest the use of SELM as a putative 
marker for hepatocellular carcinoma (Guerriero et al., 2014).  
The connection of some selenoproteins with specific pathologies 
initiates attempts to determine their role in the signaling pathways of 
these pathogenetic processes. So again, researchers point out that sele-
noproteins can inhibit carcinogenesis by counteracting oxidative dama-
ge and mutations. But under conditions of an initially high level of oxi-
dative damage, the activity of selenoproteins can cause resistance to 
apoptosis and chemotherapy in cancer cells. Plenty of selenoproteins 
have different effects in signaling pathways such as MAPK, AKT, 
VEGF and c-Met and others. Thus, the modulation of the pool of sele-
noproteins by adding Se does not always have a beneficial effect, and in 
some cases can be harmful (Short & Williams, 2017).  
In the epithelium of the prostate gland the expression decrease of a 
large number selenoproteins provokes oncogenesis. It is achieved by 
deletion of the gene encoding tRNA Sec selenocysteine residue. 
The latter one is used for inserting the selenocysteine residue into sele-
noproteins during their translation. In mice with the sec tRNA gene 
knockdown, neoplastic changes were detected in all prostate lobes, 
which progressed to dysplasia and microinvasive cancer. Moreover, the 
removal of the tumour suppressor and the introduction of the oncogen 
are not required to initiate oncogenesis. Simultaneously, there is an 
increase in lipid peroxidation markers due to a decrease in the antioxi-
dant effect of selenoproteins (Luchman et al., 2014).  
And relatively recently, the association of alleles of selenoprotein S 
and selenoprotein P, glutathione peroxidase 4 with a high risk of aortic 
occlusion disease and peripheral artery disease has been identified. 
There is also a summation of the effect of these genes on the risks of 
abdominal aortic aneurysm and aortic occlusion disease. The relation-
ship of heart failure with the allele SEPP1 and elevated concentrations 
of SeP is revealed (Strauss et al., 2018).  
At the model of heat stress, which suppresses myogenic differentia-
tion and disrupts the development of muscle tubes, the expression of 
mRNA of 24 genes encoding selenoproteins was studied. Obviously the 
heat stress enhances the expression of 18 selenoproteins after 4 days of 
hyperthermia, 11 selenoproteins after 6 days and 8 selenoproteins after 
8 days. Only a decrease in the expression of deiodinase 2 was observed 
after 6 days. Such a reaction to heat stress can be considered as a protec-
tive effect of selenoproteins on damage associated with hyperthermia in 
myoblast cells (Tang et al., 2018).  
The data of the some selenoproteins participation in the amyloid-β 
(Aβ) modeling are interesting. So, selenoprotein P (SelP-H) and mutant 
selenoprotein M (SelM) have ability to bind transition metal ions and 
modulate Zn2+-mediated amyloid-β (Aβ) aggregation, generation of 
reactive oxygen species and neurotoxicity. Aggregation and cytotoxi-
city of amyloid-β (Aβ) peptide with transition metal ions in neurons 
take part in the progress of Alzheimer's desease. The binding of Aβ with 
Zn2+ suppress Aβ fibrillation, but the SelP-H and SelM may have sig-
nificantly restored Aβ fibrillation, which is confirmed by fluorescence 
and electronic microscopy. Interestingly, both SelP-H and SelM inhibit 
Zn2+–Aβ-induced neurotoxicity and intracellular production of reactive 
oxygen species in living cells. Studies show that SelP and SelM can 
play prominent roles in regulating redox balance as well as metallic 
homeostasis (Du et al., 2013).  
High expression of selenoprotein T is observed in immature tissues 
during embryogenesis, and also remains in the endocrine glands, such 
as the pituitary gland, pancreas, thyroid gland and testes, which indica-
tes the important role of this selenoprotein in the production of hormo-
nes. With a baseline low expression of SELENOT in the brain, knock-
down of selenoprotein T causes morphological rearrangements of the 
brain of mice affecting their behaviour. Moreover, enhanced induction 
of selenoprotein T was found after brain damage, which indicates its 
protective role. The role of SELENOT in the mechanisms of insulin and 
corticotropin release has also confirmed (Anouar et al., 2018).  
The search for new selenoproteins and the decoding of their amino 
acid sequence, specific mRNA, expression levels in tissues and organs, 
and the role in signaling molecular interactions continue. For seleno-
protein U, an amino acid sequence of 224 amino acids was described in 
the chicken model. The same model revealed a decrease in the levels of 
specific mRNA and expression of U selenoprotein in muscles, liver, 
kidneys, heart, spleen and lungs of animals with selenium deficiency. 
At the same time, expression levels in the brain and testes remain un-
changed (Jiang et al., 2015).  
A connection is established between the level of selenium and the 
activity of a number of functional systems. The relationship between the 
membrane transporter ZIP8 and the level of Se in the liver was revealed. 
ZIP8 knockout mice showed a significant decrease in Se, which leads to 
the inhibition of selenium-containing glutathioneperoxidase 1 and 2. 
It was concluded that ZIP8 plays an important role in maintaining nor-
mal liver function, probably through the regulation of Se homeostasis 
and redox balance (Liu et al., 2018).  
In most models used to study the functional roles of selenoproteins, 
mice are used as biological objects. However, the mouse model widely 
used to study the physiology of selenoproteins has differences com-
pared to humans. So, for example, deletion of the iodothyronine-deiodi-
nase gene causes insignificant phenotypic changes in mice, but is lethal 
for humans. However, knockdown by thioredoxin reductase 2 and 
glutathione peroxidase 4 has been lethal for mice, but is easily tolerated 
by humans. At the same time, knockdown of the glutathione peroxidase 
gene 1 and 2 is tolerable for both mice and humans, while knockdown 
187 
 
Regul. Mech. Biosyst., 2020, 11(2) 
of thioredoxin reductase 1 and selenoprotein T is intolerable for both 
(Santesmasses et al., 2019).  
Studies of the role of selenoproteins are only at an early stage and 
many attempts must be made to establish accurate molecular signaling 
mechanisms by which certain selenoproteins affect carcinogenesis, 
embryogenesis, inflammatory, redox and neurodegenerative processes. 
Once identified, this knowledge will be projected onto the individual 
parameters of a person and will allow modulating the complex pathoge-
netic processes of many diseases. Important in our opinion is maintain-
ning the constant interest of the scientific community in the problem of 
studying this functionally active group.  
The article made an attempt to analyze and systematize the latest 
ideas about the participation of selenoproteins in signaling pathways.  
 
Signaling pathways mediated by selenoproteins  
of the ER membrane (Sel N, SelK, SelT)  
 
Recessive genes encode selenoprotein N and RYR1, proteins that 
regulate skeletal muscle calcium homeostasis, cause severe congenital 
myopathies. An increase in the level of class II histone deacetylases 
(HDACs), which cause hypoacetylation and, as a result, repression of 
the selenoprotein N and RYR1 genes, has been revealed. Along with 
this, there is an increase in DNA methyltransferases, which catalyze the 
methylation of nucleotide residues in the DNA, which leads to a change 
in the properties of DNA, while changing the activity, functions of the 
corresponding genes, as well as the spatial structure of the nucleic acid. 
Genomic DNA methylation analysis of patients with RYR1 and 
SELENON variants revealed more than 3,500 common aberrantly 
methylated genes, many of which are involved in calcium signaling 
(Bachmann et al., 2019).  
The knockdown of selenoprotein N caused by mutations in the cor-
responding gene, in addition to myopathy, leads to a deterioration in 
insulin signaling in skeletal muscle, as indicated by a decrease in Akt 
phosphorylation and an exaggerated ER stress, which indicates a corre-
lation between a decrease in glucose tolerance of the body, insulin acti-
vity and increased ER stress in the muscles (Varone et al., 2019).  
It was found that the levels of selenoprotein N (SEPN1) are parallel 
to oxidoreductin 1 (an enzyme of the family of oxidoreductases) and 
thioloxidase located in ER. SEPN1 protects the endoplasmic reticulum 
from peroxides produced by oxidoreductin 1. SEPN1 also enhances the 
activity of SERCA2 (endoplasmic reticulum pump for calcium imports) 
by reducing the amount of cysteines in the lumen that are hyperoxidized 
by peroxides generated by oxidoreductin 1. Cells lacking SEPN1 are 
hypersensitive to overexpression of oxidoreductin 1 and become defec-
tive upon reabsorption of calcium by the endoplasmic reticulum (Mari-
no et al., 2015).  
Deletion of SEPN1 alters endoplasmic reticulum uptake of Ca2+, 
causing an ER stress response, including expression of oxidoreductin 
(ERO1). The latter transfers the redox potential of ER to a more oxi-
dized state and thereby enhances its effect on Ca2+ uptake. The above 
confirms that SEPN1 is part of the stress-dependent antioxidant ER 
response and that the CHOP/ERO1 branch of the ER stress response is 
the new pathogenic mechanism underlying SELENON-related myopa-
thies (Pozzer et al., 2019) (Fig. 1).  
  
Fig. 1. The signaling pathway is mediated by SelN and oxidoreductin  
ER – membrane of endoplasmic reticulum, SelN – selenoprotein N  
The model of chicken myoblasts confirms the relationship between 
selenoprotein K and gga-let-7f-3p, namely, selenoprotein K is the target 
of gga-let-7f-3p. It is revealed there is a direct effect of knockdown and 
overexpression of gga-let-7f-3p on the expression of selenoprotein K. 
The gga-let-7f-3p-selenoprotein K pathway plays a key role in Se defi-
ciency-induced muscle damage through induction of oxidative stress 
and ERS, which ultimately contributed to apoptosis (Fan et al., 2018).  
In an isolated rat heart model, the effect of ischemia/reperfusion on 
SelT expression lead to increases in the latter. The authors also proposed 
the use of a derivative of selenoprotein T, SelT43-52, which exhibits a 
cardioprotective effect after ischemia/reperfusion. Cardioprotection of 
SelT derivative is accompanied by a significant increase in phosphory-
lated Akt, Erk-1/2 and Gsk3α-β and a decrease in p38MAPK. In addi-
tion, SelT43-52 inhibits the proapoptotic factors Bax, caspase 3, and 
cytochrome C and stimulates the antiapoptotic factor Bcl-2. The above 
indicates the effect of SelT as a modulator of cardiac tissue (Rocca 
et al., 2018).  
An attempt was made to study the effects of SelK in human chori-
ocarcinoma (CCA). The effects of knockdown and overexpression of 
SelK on the expression of the beta subunit of human chorionic gonado-
tropin (β-hCG) were studied on a CCA, BeWo, JEG-3, and JAR cell 
model. It was found that β-hCG levels are regulated and directly propor-
tional to SelK levels. In JEG-3 cell culture, an increase in proliferative, 
migratory, and invasive abilities was noted in SelKknockdown and a 
decrease in these activities was observed during SelK overexpression. 
An interesting fact is that β-hCG affects SelK levels. The aforemen-
tioned confirms that β-hCG acts as a promoter of human choriocarci-
noma, while SelK appears as a suppressor. The influence of both is via 
the ERK/p38 MAPK and Akt signaling pathways (Li et al., 2018).  
Recent studies have shown that selenoprotein K (SelK), as an ER 
transmembrane protein, is involved in ER responses to stress and cal-
cium-dependent signal transmissions. SelK in the ER membrane binds 
to an enzyme protein called DHHC6, resulting in the formation of the 
SelK/DHHC6 complex, which carries out palmitoylation in target pro-
teins. One of these proteins is the inositol 1,4,5-triphosphate receptor 
(IP3R), which is responsible for the stabilization of the calcium channel 
in the ER membrane. SelK-lowering conditions disrupt the calcium 
flow provided by IP3R. This signaling pathway is involved in the proli-
feration and activation of immune cells, and has also recently been 
described in the progression of melanoma (Marciel & Hoffmann, 2019) 
(Fig. 2).  
 Fig. 2. IP3R signaling pathway and SelK IP3R – inositol triphosphate 
receptor, DHHC6protein-palmitoyltransferase, SelK – selenoprotein K,  
ER – endoplasmic reticulum membrane  
It was found that SelT is expressed in the membrane of the endop-
lasmic reticulum in all pituitary cells secreting hormones. Deletion of 
SelT in corticotropocyte cells promotes the development of a detailed 
protein response (UPR) and ER stress and reduces protein degradation 
associated with the endoplasmic reticulum (ERAD) and hormone pro-
duction (Hamieh et al., 2017).  
The function of SelK in the process of the immune response was 
investigated. Short hairpin RNA was used to suppress SelK expression 
in vitro. Knockdown of SelK decreases the expression of the CHERP 
protein, the endoplasmic reticulum protein that appears in calcium 
transport, and also reduces the concentration of free calcium inside the 
cell. Simultaneously, the expression of the alpha chain of the interleu-
kin-2 receptor (IL-2Rα) and the secretion of interleukin-4 (IL-4), which 
plays key roles in the proliferation and activation of T-lymphocytes, 
decreases. Selenomethionine excludes the above effects from Sel-
188 
 
Regul. Mech. Biosyst., 2020, 11(2) 
Kknockdown and reverses the change in the expression of CHERP and 
intracellular free calcium (Wang et al., 2017) (Fig. 3).  
  
Fig. 3. Ca2+ transport regulation by SelK and CHERP protein  
CHERP – endoplasmic reticulum protein regulator of calcium homeos-
tasis, SelK – selenoprotein K  
The development of melanoma, according to research, requires the 
expression of selenoprotein K, which is necessary for the Ca2+ flux into 
the cancerous cell. Malignant cells show a strong dependence on the 
flow of calcium. In the experiment CRISPR/Cas9 was used to form the 
selenoprotein K deficiency in human melanoma cells. This led to a de-
crease in the Ca2+ flux and impaired function of the specialized receptor 
(IP3R), which inhibited proliferation, invasion, and cell migration. Con-
sequently, the tumour growth, its metastatic potential depends on the 
selenoprotein K synthesis in the cancer cell (Marciel et al., 2018).  
The effect of selenoprotein N on smooth muscle cells of the myo-
metrium is described. For this, mRNA levels were determined on the 
mouse model using polymerase chain reaction. Protein was determined 
by Western blotting. An immunohistochemical analysis of myometrial 
tissues was also carried out. When selenium is added to the smooth 
muscle of the uterus the output of Ca2+, Ca2+-calmodulin increases. 
At the same time, the expression of myosin pulmonary kinase and 
phosphorylation of the myosin light chain are stimulated, but the 
amount of reactive oxygen species does not change (Zhou et al., 2018).  
A number of authors describe in detail the active interaction of 
Ero1α (ER disulfide oxidase promoting tumour progression) with 1,4,5-
triphosphate inositol receptors (IP3Rs) or selenoprotein N (SEPN1) 
with the sarco/endoplasmic Ca2+ transport network of ATPase 2 
(SERCA2) (Appenzeller-Herzog & Simmen, 2016).  
The BGC-823 gastric cancer cell model, which overexpressed 
SelK and was placed in Matrigel composition, showed a significant 
decrease in adhesive and migration ability compared to non-SelK ex-
pressing cells. By comparing these parameters, overexpression cells and 
cells with expression of truncated SelK the decrease is not revealed. The 
same indicators of adhesion and migration have emerged in the culture 
of embryonic kidney cells HEK-293, which overexpressed SelK. 
In addition to the above, SelK overexpression causes loss of viability 
and stimulates apoptosis of cancer cells (BGC-823). At the same time, 
the level of cytosolic calcium is significantly increased in these cells. 
However, overexpression of SelK in HEK-293 cells does not reduce 
viability and does not stimulate apoptosis. Thus, the authors emphasize 
that SelK reduces the adhesion and migration of cancer cells and at the 
same time inhibits their viability by inducing apoptosis. Presumably, 
this effect is through the release of calcium from the endoplasmic reticu-
lum. And only a full-sized protein is capable of exerting such an effect 
(Ben et al., 2015).  
One of the mechanisms of activation of immune cells is associated 
with an increased flow of calcium from the endoplasmic reticulum into 
the cytosol, which occurs after the binding of inositol-1,4,5-triphosphate 
(IP3) to the receptor in the IP3 endoplasmic reticulum (IP3R). The ef-
fect of SelK on this chain of signal effects is revealed. Namely, when 
SelK was knocked down, IP3 generation did not decrease, while IP3R 
expression was significantly reduced due to violation of palmitoylation 
of IP3R. Using immunofluorescence and co-immunoprecipitation me-
thods, an interaction is revealed between SelK and the membrane do-
main of the enzyme responsible for palmitoylation (DHHC6). Knock-
down of the latter leads to a decrease in IP3R expression and disruption 
of the IP3R-dependent Ca2+ flux. Thus, the effect of SelK on an impor-
tant molecular pathway that regulates the function of IP3R and through 
this mechanism the flow of calcium, and, accordingly, the activation of 
immune cells, was discovered (Fredericks et al., 2014).  
 
Signaling pathways mediated  
by ER lumen selenoproteins (SelF, SelS, SelM)  
 
The interaction of SelS and valosin-containing protein (VCP) of the 
ER membrane provides the insert of selenoprotein K into the ER mem-
brane. This interaction manages Sel K insertion. It was established that 
in tissues where selenoprotein S is eliminated, selenoprotein K does not 
interact with a valosin-containing protein, but the elimination of seleno-
protein K does not affect this intercommunion. In turn, ER stress leads 
to an increase of SelK and Sel S expression (Lee et al., 2015) (Fig. 4).  
  
Fig. 4. Regulation of Sel K incorporation through by VCP, and Sel S 
influence VCP – valosine-containing protein, Sel K – selenoprotein K, 
SelS – selenoprotein S  
The study revealed the effect of selenoprotein M on the prolifera-
tion and metastasis of renal cell carcinoma by activating the PI3K/Akt/ 
mTOR pathway, which is one of the main signaling intracellular path-
ways and provides cell growth, cell proliferation, metabolism and 
avoidance of apoptosis. Overexpression of selenoprotein M activates 
this pathway, as well as overexpressed cells reveal an increase in N-
cadherin, β-catenin, vimentin, which are known to be positively asso-
ciated with tumour progression, metastasis and cancer prognosis and are 
markers of the epithelial-mesenchymal transition (Jiang еt al., 2019).  
The effect of selenoprotein M on hypothalamic signaling via leptin 
was studied in vivo and in vitro. Leptin supports the expression of sele-
noprotein M in the hypothalamus, however, knockdown of Sel M inter-
rupts the phosphorylation of STAT3 (an intermediary protein that pro-
vides a cell response to signals through interleukin and growth factor 
receptors) with leptin (Fig. 5). In vitro it is confirmed on the model of 
hypothalamic neurons. Conversely, overexpression of Sel M enhances 
leptin sensitivity. A large number of genes have been revealed in the 
hypothalamic tissue which is affected by Sel M deficiency, including a 
protein interacting with thioredoxin, a negative regulator of the TXN 
system. In general, these data confirm that Sel M is a positive regulator 
of leptin signaling and TXN antioxidant activity in the hypothalamus 
(Gong et al., 2019) (Fig. 5).  
  
Fig. 5. Regulation of STAT3 phosphorylation by leptin  
in the hypothalamus STAT3 – a mediator protein that provides  
cell response to signals transmitted through interleukin receptors  
and growth factors; Sel M – Selenoprotein M  
Using a Hek293 cell model, it was found that overexpression of 
HSF1 (heat shock factor) and activation of heat shock increases promo-
ter activity and levels of mRNA and SELENOF protein (Selenoprotein 
F) as well as sodium selenite treatment. This can be regarded as the fact 
that overexpression and knockdown of HSF1 show the influence of 
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HSF1gene transcription regulation on SELENOF and revealed the mo-
lecular mechanism of regulation of the SELENOF gene by the HSF1 
participation in selenotranscriptome (Ren еt al., 2019).  
In the cell line 3T3-L1 (preadipocytes) with the SelS gene deletion 
by imbalance of the most important regulator of apoptosis Bcl-2 (con-
trols the permeability of the mitochondrial membrane), cell death oc-
curs. Knockdown SelS increases the level of IRE1α protein (a key 
player that alters gene expression during stress of the endoplasmic reti-
culum) and p-JNK (activate apoptotic signaling), and also reduces 
XBP1 (it is a transcription factor that regulates the expression of genes 
important for the proper functioning of the immune system and cellular 
response to stress) (Fig. 6). This indicates the SelS modulation of the 
IRE1α-sXBP1 signaling pathway. The aforementioned suggests that 
SelS promotes cell survival through the IRE1α-XBP1 signaling path-
way (Men et al., 2018).  
  
Fig. 6. The influence of SelS in preadipocyte cells on key signaling 
pathways IRE1α – inositol transmembrane kinase/endoribonuclease 1α, 
a modulator of gene expression; p-JNK – Jun N-terminal kinases,  
activator of apoptotic signaling; XBP1 – Xbox binding protein,  
a regulator of genes important for the normal functioning  
of the immune system  
Using the mouse hepatoma model, the effect of reactive oxygen 
species on apoptosis and necrosis during silencing of selenoprotein S 
was studied. It was found that knockdown of selenoprotein S damages 
intracellular calcium homeostasis, stimulates mitochondrial dynamic 
disorder, ROS accumulation, ATP loss and causes apoptosis and necro-
sis in cells, however ER stress does not happen. This indicates that SelS 
silence initiates apoptosis and necrosis in cells by acting on intracellular 
calcium homeostasis, and ROS-mPTP-ATP is involved in the trans-
formation of cell death from apoptosis to necrosis to increase damage 
(Li et al., 2018).  
Using a model of cells with and without SelS knockdown, when 
comparing osteoblastic differentiation and calcification of smooth mus-
cle cells, it was revealed that the lipopolysaccharide activates both clas-
sical and alternative nuclear signal transduction pathways-κB (NF-κB) 
during calcification under SelS knockdown conditions. In addition, 
disabling SelS enhances lipopolysaccharide-induced generation of pro-
inflammatory cytokines, expression of TNF-α and interleukin-6. Thus, 
through inhibition of NF-κB signaling pathway activity and ERstress 
SelS can suppress inflammation-induced calcification (Ye et al., 2018).  
Selenoprotein M is considered as thiol-disulfide oxidoreductase 
which provides the formation of disulfide bonds. The last one determi-
nes involvement in Сa transfer. A direct relationship is established bet-
ween the expression levels of selenoprotein M and changes in redox 
homeostasis. It is stipulated by presence of selenocysteine residue. 
A strong bond between levels of dietary selenium and selenoprotein M 
is also determined (Guerriero et al., 2014).  
In the model of human kidney embryonic and mouse neuroblasto-
ma cells cultures forcing of ER stress leads to raising of selenoprotein S 
expression. These events are bound by a mechanism of interaction 
between membrane protein p97 and selenoprotein (Lee et al., 2014).  
In cell culture, ochratoxin induction of cytotoxicity and apoptosis is 
suppressed by overexpression of selenoprotein S, while the level of 
glutathione also increases, the number of reactive oxygen species de-
creases, and ochratoxin-induced phosphorylation is inhibited. Knock-
down of selenoproten S has the exact opposite effect: it enhances phos-
phorylation, increases the number of reactive oxygen species and re-
duces the level of glutathione (Gan et al., 2017).  
Increased expression of selenoprotein S in separate endothelial cells 
undergoing the impact of tumour necrosis factor (TNF-) leads to the 
raising of nitric oxide and nitric oxide synthase. TNF-induced adhesion 
of THP-1 cells to endothelial cells is blocked by excess expression of 
selenoprotein S and manages such factors of inflammation as interleu-
kin-1, interleukin-6, and interleukin-1. The knockdown of selenoprotein 
S leads to the opposite effects (Cui et al., 2018).  
Selenoprotein F provides monitoring of protein folding and deletion 
of selenoprotein F RNA suppresses cell proliferation, cell growth. 
The latter processes restore after the riddance of knockdown factor. 
Lack of selenoprotein F blocks cells in G1 phase, the ER stress also 
takes place. Due to selenoprotein F knockdown, adhesive cell junctions 
shift into the basal part of the cell, which leads to the reduction of inva-
sive and migration abilities. The levels of selenoprotein F determine 
invertibility of the aforementioned events (Bang et al., 2015).  
With an insufficient amount of SelF, an ultramicroscopic examina-
tion reveals the appearance of membrane vesicles in them, an increased 
amount of such endosomes leads to cell shape transformation from 
spindle to round shape. In this case, actin fibrils are shifted to the peri-
phery and alpha-tubulin overlaps. Rho-associated protein kinase inhibi-
tors inhibit and reverse these changes. Despite the presence of vesicles, 
cells with deficiency of Sel F are not apoptotic and there is an exact 
arrangement of F-actin and -tubulin. Thus, selenoprotein F acts as a 
pathway regulator that counteracts RhoA/ROCK/MLC-dependent 
nonapoptotic vesicle construction (Bang et al., 2015).  
Overexpression of selenoprotein M in mouse hippocampal cells, 
cerebellar astrocytes and neurons does not ensure the survival of these 
cells when exposed to hydrogen peroxide, although it reduces the num-
ber of reactive oxygen species to a significant extent. Overexpression 
also leads to a decrease in the influx of calcium into the cells with simul-
taneous exposure to peroxide, and vice versa, a decrease in the expres-
sion of selenoprotein M increases the cytosolic concentration of cal-
cium. Cell death by apoptosis also occurs when the selenoprotein M is 
completely knocked down, and the number of dead cells is comparable 
to the number when exposed to hydrogen peroxide on the background 
of overexpression (Mariclair еt al., 2010; Reeves et al., 2010).  
 
Signaling pathways mediated by selenoproteins of the cell  
nucleus (SelH, SelR or methionine-R-sulfoxide reductase 1)  
 
SelH deficiency exacerbates oxidative stress-dependent activation 
of p53 (a malignant tumour suppressor), where inflammation is a key 
factor in gastrointestinal oncogenesis in the zebrafish model (Cox et al., 
2016). Recently the new nuclear selenoprotein H was described. Ac-
cording to the classification of enzymes, it is recognized as nucleolar 
oxidoreductase. It is assumed that it manages redox-homeostasis and 
can prevent some DNA damages (Cox et al., 2016).  
It is established that selenoprotein H takes part in both redox regula-
tion and in carcinogenesis. The tumour tissue and undifferentiated tis-
sues in the stomach and intestine epithelium show high expression of 
selenoprotein H. But a knockdown of selenoprotein H leads to a de-
crease of cell differentiation, stimulates proliferation and migration. 
Knockdown of selenoprotein H initiates colonization of tumours and 
xenografts. Changes in cell cycle include an increase in the rate of all 
phases. So, selenoprotein H plays the role of cell cycle regulator and 
control proliferation (Bertz et al., 2018).  
 
Signaling pathways mediated by cytoplasm selenoproteins  
(SelP, SelW, SelR, SelІ)  
 
A regulatory role in the osteogenic differentiation of bone marrow 
mesenchymal cells has been revealed of a new long non-coding RNA, 
Bmcob, whose gene is located next to the gene encoding selenoprotein 
R. The selenoprotein P gene affects the Bmcob regulatory effects. Mo-
reover, some selenoproteins were suppressed by a Bmcob knockdown. 
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As a result, it was revealed that a new long non-coding RNA affects the 
protein that binds the sequence of insertion of selenocysteine 2 into 
selenoproteins, which is a key point in the synthesis of selenoproteins. 
The authors suggest that Bmcob regulates the expression of a number of 
selenoproteins, including P selenoprotein, and thereby mediates osteo-
genesis of bone marrow mesenchymal cells (Sun et al., 2018).  
Analysis of gene expression of selenoproteins under the influence 
of metallic mercury vapour showed a significant increase in the expres-
sion of selenoprotein P and GPX1 (glutathione peroxidase 1) (Kuras 
et al., 2018).  
Selenoprotein P is considered by some authors as a diagnostic bio-
marker and antiproliferative factor in pulmonary arterial hypertension 
due to the fact that SelP knockout mice exhibit reduced pulmonary 
hypertension caused by hypoxia. Conversely, mice with increased SelP 
expression show an increase in pulmonary hypertension provoked by 
hypoxia. Also, SelP promotes proliferation of PASMC (smooth muscle 
cells of the pulmonary artery) and apoptosis resistance through increa-
sed oxidative stress and mitochondrial dysfunction, which were associa-
ted with activated hypoxia-induced factor-1α and metabolic dysfunction 
glutathione. SelP contributes to the development of pulmonary hyper-
tension, suggesting that it is a new biomarker and therapeutic target for 
the disorder (Kikuchi et al., 2018).  
The effect of SelP on ischemia/reperfusion damage was studied in a 
mouse model with and without SelP knockout. The infarction zone after 
reperfusion was significantly smaller in the case of SelP knockout. 
The TUNEL (method for detecting fragmentation of apoptotic DNA) 
has revealed a significant decrease in TUNEL-positive nuclei with SelP 
knockout, which indicates the suppression of apoptosis. At the same 
time, the level of caspase-3 activation decreased. Evaluation of phos-
phoinositide-3-kinase/Akt and Erk in knockout mice shows an increase 
in phosphorylation of these enzymes after ischemia/reperfusion in com-
parison to wild-type mice, which indicates activation of the transmem-
brane PI3K/Akt/Erk signal pathway. Overexpression according to the 
authors leads to an increase in myocardial infarction zone after ischemia 
/reperfusion in comparison with knockout. Thus, inhibition of SelP has 
a cardioprotective effect in ischemia/reperfusion via the RISK signaling 
pathway (Chadani et al., 2018).  
In the model of hepatocytes, cell culture glucose injection enhances 
expression and transcription of selenoprotein P. In the model of human 
umbilical vein endothelium usually vascular endothelial growth factor 
(VEGF) stimulates cell proliferation, but the normal amount of seleno-
protein P reduces the latter and tubular formation, migration too. Sele-
noprotein P also suppresses emerging and phosphorylation of reactive 
oxygen species, which are induced by endothelial growth factor 
(VEGF). Selenoprotein P inhibits extracellular signaling regulated kina-
se in the same model. Recovery from injuries is inhibited by expression 
of selenoprotein P, while knockdown stimulates (Ishikura et al., 2014).  
Selenoprotein P, as one of liver secretory proteins is engaged in re-
sistance to insulin. Administration of native selenoprotein P breaks 
down insulin signals and manages insulin function in both hepatocytes 
and myocytes. Knockdown and exclusion of selenoprotein P enhance 
common reactivity to insulin and glucose tolerance in mice. Adenosine 
monophosphate-activated protein kinase (AMPK) in the last case plays 
as a mediator in the regulatory activity of selenoprotein P. The afore-
mentioned suppose the use of selenoprotein P as a therapeutic target in 
diabetes 2 types (Misu et al., 2010).  
Deficiency of selenoprotein P shapes a "super-sustainability" feno-
type in mice after training and intensifies reactive oxygen species gener-
ation, phosphorylation of protein kinase. It also provides activation of 
the proliferative receptor with peroxide. N-acetylcysteine antioxidant 
diminishes the production of reactive oxygen species and durability in 
selenoprotein P deficient mice (Misu et al., 2017).  
In a living organism, there is a so-called selenium pool, which is 
controlled in order to provide vital selenoproteins with the necessary 
trace element. The central regulatory organ of the pool is the liver, 
which, in a situation of selenium deficiency, releases SelP into plasma. 
A special receptor for SelP, 2 apolipoprotein E, expressed in different 
degrees by tissues, determines the distribution of SelP in the correspon-
ding tissues, being a source of the necessary selenocysteine residue for 
them. In the kidneys, N-terminal forms of SelP are filtered, with conse-
quent reabsorption in the proximal convoluted tubules using the mega-
line receptor (Burk et al., 2015).  
Against the background of inflammatory colitis, there is an increase 
in carcinogenesis during mutations and SelP deficiency in mice. In this 
case, changes in the pro-tumour microenvironment occur. A decrease in 
SelP increases the number of so-called M2-polarized macrophages. 
Complete removal of SelP in a cancer cell culture increases the number 
of stem cells among them, indicating an increase in proliferative activi-
ty; significantly increases the production of reactive oxygen species and 
DNA damage. Simultaneously a decrease in cell viability, a change in 
signal transfer in the WNT signaling pathway caused by oxidative stress 
is noted (Barrett et al., 2015).  
Rat myoblasts were placed in a composition containing mouse se-
lenoprotein P in order to increase the activity of glutathione peroxidase 
Gpx. It was revealed that shutdown of the apoER2 (a receptor that binds 
Selenoprotein P and effecting its endocytosis) inhibits Se uptake from 
(75) Se-labeled Selenoprotein P (Fig.7). Thus, myoblasts absorb Sele-
noprotein P by apoER2-linked mechanism. At the same time, tissues 
express apoER2 differently (Kurokawa et al., 2012).  
The data on the pathways providing the uptake of SelP by brain 
neurons are interesting. In the brain, SelP is expressed by astrocytes, the 
further transport of selenoprotein P through the blood-brain barrier is 
carried out by binding to LRP2 (lipoprotein-like protein, or megaline, 
which is a membrane multiligand receptor, Fig. 7) or LRP8 (apolipo-
protein with membrane receptor function) (Gong et al., 2018).  
 
Fig. 7. Transmembrane receptor-mediated transfer of SelP in myoblasts  
and neurons SelP – selenoprotein P, apoER2 – apolipoprotein E  
receptor, LRP2 – lipoprotein-related protein receptor or megalin  
Four isoforms of selenoprotein P were isolated, while the longest 
forms bind to the apoER2 receptor, with six or more selenocysteines in 
the HEK293T cell culture (embryonic renal cells). Moreover, binding 
occurs with the C-terminal domain of selenoprotein P, the N-terminal 
domain is not involved in this (Kurokawa et al., 2014).  
Since apoER2 is expressed by tissues to varying degrees, but most 
of all in the brain, it was experimentally confirmed that knockout of 
selenoprotein P or apoER2 reduces selenium in the brain from about 
120 to about 50 ng/g and leads to severe neurodegeneration and death 
with mild selenium deficiency. It was also found that apoER2 binds 
selenoprotein P through the blood-brain barrier. In the case of a knock-
out for selenoprotein P and apoER2, selenium in the brain decreases to 
35 ng/g, and severe neurodegeneration develops. Thus, the dual effect 
of selenoprotein P and apoER2 on the transfer of selenium to neurons is 
not in doubt. It is apoER2 in the blood-brain barrier that transfers sele-
nium to neurons (Burk et al., 2014).  
 
Thioredoxin reductase-mediated signaling pathways  
 
Participating in many regulatory functions, selenoproteins are con-
trolled by other regulators. For instance, Nrf2, a regulatory protein, af-
fects selenoproteins such as thioredoxin reductase-1 (TrxR1) and gluta-
thione peroxidase-2 (GPx2). Moreover, deficiency of selenium and 
knockdown of TrxR1 stimulates Nrf2. However, it creates the opposite 
effect in cancer cells. Hyperproduction of TrxR1 and GPx2 caused by 
Nrf2 makes cancer cells resistant to chemotherapy, and protects them 
from oxidative damage. TrxR1 activation has been observed to support 
the proliferation of cancer cells. The anti-inflammatory activity of GPx2 
suppresses the pro-inflammatory effects of the tumour, which also con-
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tributes to its development. The effects of Nrf2 also depend on the stage 
of the cancer (Brigelius-Flohé et al., 2012).  
In the case of multiple myeloma, inhibition of Trx1 by sensitized 
pheochromocytoma cells (PX-12), and TrxR1 with Auranofin disrupts 
redox homeostasis, which causes apoptosis in myeloma cells and re-
duces their proliferative activity. Knockdown of Trx1 and TrxR1 also 
reduces the viability of these cells. When Trx1 is inhibited in cells, resis-
tance to BAY 11-7082, and curcumin, which serve as inhibitors of NF-
κβ, one of the key signaling pathways, decreases (Raninga et al., 2015).  
Inhibition of TrxR1 reduces hypoxia-induced levels of p65 NF-β 
protein in the nucleus and reduces the expression of NF-β-regulated 
genes in myeloma cells. Thus, inhibition of TrxR1 has an inhibitory 
effect on the NF-kβ signaling pathway (Raninga et al., 2016).  
A study of salivary adenoid cystic carcinoma metastases (SACC) 
found that TGF-β plays a key role in the epithelial-mesenchymal transi-
tion in metastatic SACC. It was revealed that selenium-containing thi-
oredoxin reductase (Trx) affects the TGF-β-induced epithelial-mesen-
chymal transition. Metastatic SACC revealed significantly increased 
expression of Trx and N-cadherin and lower expression of E-cadherin 
compared to non-metastatic SACC tissues. Trx and Akt inhibitors re-
duced the proliferation and invasion of these cells. As a thioredoxin 
reductase inhibitor, BBSKE was used. The authors conclude that Trx 
plays a key role in the invasion and metastasis of SACC through its 
effect on TGF-β-Akt/GSK-3β pathway during epithelial-mesenchymal 
transition (Jiang et al., 2015).  
Two metastatic phenotypes (C1 and C6) and two weakly metastatic 
variants (C4 and C5) were isolated from osteosarcoma. In metastatic 
types, overexpression of thioredoxin reductase 2 (TXNRD2) is deter-
mined, and in the unneoplastic bone tissue, the level of expression of 
TXNRD2 do not change. Using the thioredoxin reductase 2 inhibitor 
Auranofin in small doses does not significanly decrease cell viability, 
while high doses of this inhibitor stimulated ROS-dependent apoptosis 
(Topkas et al., 2016).  
The CT26 mouse colon carcinoma cell model examined the effects 
of Sep15 and thioredoxin reductase 1 on tumorigenesis. The authors 
note that the combined deficit of Sep15 and Thx 1 completely changes 
the anticancer effects that are observed when each of them was sup-
pressed. In Sep15-deficient cells, the γ-interferon-regulated guanilate-
binding proteins modulating inflammation were significantly reduced, 
which do not occur with a deficiency of Thx 1. It is interesting that mes-
sengers of the Wnt/β-catenin signaling pathway were increased in cells 
with a deletion of both Sep15 and Thx1. Thus, the authors conclude that 
Sep15 and TR1 actively modulate important signaling pathways in 
colon cancer cells (Tsuji et al., 2015).  
A clear connection between thioredoxin reductase 1 and the forma-
tion of various tumours, including breast tumours, was determined. 
Overexpression of thioredoxin reductase 1 (TrxR1) is directly correlated 
with tumorigenesis. In the model of MCF-10A cells (normal breast 
cells) exposed to H2O2. The prolonged exposure of H2O2 to cell culture 
triggered an increase in TrxR1 expression and activity. At the same 
time, the cells show high malignancy. The use of an ethaselen inhibitor 
(BBSKE) partially reversed the epithelial-mesenchymal transition of 
MCF-10A and MCF-7 cells (mammary adenocarcinoma cells) (Dong 
et al., 2016).  
Breast carcinogenesis is induced in a mouse model using 7,12-di-
methylbenzylbenz[a]antracene in the line of heterozygous deletion of 
the Trsp gene (thioredoxin reductase) and homozygous line. In mice 
heterozygous for this trait, the frequency of tumours and survival do not 
differ. However, in homozygous mice, the incidence of tumours is 
54.8% compared to 36.4% in heterozygous mice and survival in homo-
zygous mice is significantly shorter. This confirms that reduced Trsp 
expression increases susceptibility to carcinogen-stimulated breast tu-
mours (Hudson et al., 2012).  
In a model of acute colitis induced by 4% dextran sodium sulfate 
with selenium deficiency and normal selenium content, the effect of 
selenoproteins, which play the role of pro-inflammatory elements in 
colitis, was studied in macrophages. Thioredoxin reductase (Trsp) 
knockout mice with normal expression showed enhanced colitis and 
decreased Trsp survival. With the addition of selenium at a dose of 0.4 
and 1.0 ppm, the manifestations of colitis decreased and survival in-
creased in both groups. At elevated levels of selenium, increased oxida-
tion of PGE2 (prostaglandin E2) was observed, which is directly related 
to the Se-dependent activation of 15-hydroxy-PG-dehydrogenase (15-
PGDH) in macrophages (Kaushal et al., 2014).  
A number of authors describing the thioredoxin reductase system 
indicate that both cytosolic (TrxR1) and mitochondrial (TrxR2) thiore-
doxin reductases modulate basic cellular circuits and cellular responses 
to stress. The results of deletion of enzymes are an increase in lipogene-
sis, insulin sensitivity, an increase in glycogen stores, aberrant embryo-
genesis, while an increase in TrxR1 and TrxR2 expression is directly 
proportional to a decrease in proliferation, an increase in life expectancy 
and a worsening in the prognosis of cancer. (Dagnell et al., 2018) (Fig. 8).  
  
Fig. 8. Intracellular effects of thioredoxin reductases 1 and 2 TrxR1 – 
cytosolic enzyme; TrxR2 – mitochondrial enzyme; ASK1 – kinase 
regulating apoptosis signaling; Prx3 – peroxyredoxin 3, an enzyme in 
the antioxidant system; Msrs – methioninesulfoxid reductase; Prxs –
peroxyredoxins; mTOR protein kinase, which is part of the signaling 
pathway that regulates cell growth and survival; AMPK – cellular  
protein kinase that controls cell energy balance  
The removal of thioredoxin reductase was studied in a model of 
mice with a breast tumour gene. Sec tRNAs were significantly reduced 
in breast tissue by more than 70% with any transgene. In other organs, 
such as the skin and spleen, a decrease in Sec tRNA occurs only in the 
line of mice with the MMTV-Cre transgene (breast tumour virus). 
In tissues affected by the tumour process, the expression of specific 
selenoproteins was different. Moreover, the levels of Sep15 and gluta-
thione peroxidases GPx1 and GPx4 were significantly reduced. Expres-
sion of BRCA1 and p53, which are responsible for tumour suppression, 
also changes. Moreover, these changes occur in MMTV-Cre transgenes 
to a greater extent. The authors emphasize tissue-specific regulation of 
selenoprotein expression during deletion of thioredoxin reductase (Ku-
maraswamy et al., 2003).  
 
Glutathione peroxidase-mediated signaling pathways  
 
In an experiment (DNA hypermethylation is observed in some 
cancers) with methylation, genes responsible for the expression of gluta-
thione peroxidase 3 (GPX3, selenoprotein) in the cell line of chondro-
cytes, the effect of oxidative stress was studied. A tendency toward a 
decrease in expression (GPX3) is revealed in the groups of non-me-
thylation, partial methylation and complete methylation. Also, in the 
partial and complete methylation groups, the protein level in the PI3K/ 
Akt/c-fos pathway (the pathway responsible for growth, proliferation, 
and avoidance of apoptosis) increased compared to the non-methylation 
group (Han et al., 2018).  
There is the pathway where the interaction between pro-inflamma-
tory factors occurs, miRNA (plays a regulatory role in post-transcrip-
tion), SBP2 (selenoprotein-binding protein) and selenoproteins that are 
associated with oxidation resistance in cartilage. It is found that IL-1β 
(pro-inflammatory cytokine) increases hsa-miR-181a-5p and reduces 
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SBP2 depending on time and dose. At the same time, GPX1 and GPX4 
are upgraded. A decreased expression of GPX1 and GPX4 mRNA and 
expression of SBP2 protein are detected in damaged cartilage but not in 
smooth cartilage from the same osteoarthritis sample, and vice versa, 
decreased expression of hsa-miR-181a-5p is also noted (Xue et al., 2018).  
Alcohol intoxication causes a depletion of Sel in the liver, which 
leads to a decrease in the expression and activity of selenium-containing 
antioxidant enzymes (GPx1, GPx4) and NF-kb, but an increase in the 
expression of caspase-3. At the same time, a decrease in the activity of 
pro-inflammatory cytokines and chemokines is noted (Ojeda et al., 2017).  
In a colorectal cancer cell culture the effect of GPx2 on the proli-
ferative and migration abilities of cancer cells was studied. Deletion of 
GPx2 reduces resistance to apoptosis caused by H2O2 and significantly 
reduces proliferative and metastatic abilities. With the elimination of 
oxygen radical forms, proliferative activity resumes. However, knock-
down of GPx2 in cells leads to a loss of their ability to differentiate, and 
such cancer cells form slowly growing undifferentiated tumours. And 
vice versa, overexpression of GPx2 leads to tumour differentiation, 
increases proliferation and growth. The same thing is noted at the usual 
level of expression. The authors also point to the great potential for early 
tumour recurrence with overexpression of GPx2. They note that the neu-
tralization of H2O2 GPx2 is necessary for the tumour to maintain prolifera-
tion, migration capabilities and differentiation (Emmink et al., 2014).  
The frequent detection of the methylation of glutathione peroxidase 3 
(GPX3) in cancer of the prostate, esophagus, stomach, and breast has 
prompted the study of this selenoprotein in thyroid cancer. In 46.8 cases, 
GPX3 is methylated, which correlated with tumour size and metastases 
to regional lymph nodes. Compared to neighboring tissue samples, 
where GPX3 expression is not changed, GPX3 expression was either 
absent or decreased in tumour tissue. The disappearance or decrease in 
GPX3 expression is associated with hypermethylation of the promoter 
region. Thus, methylation of the promoter region of GPX3 regulates the 
expression of this selenoprotein. At the same time, GPX3 suppresses 
Wnt signaling in cell colonies of papillary thyroid cancer. The authors 
emphasize that metastasis of thyroid cancer is suppressed by GPX3 by 
inhibiting Wnt/β-catenin signaling (Fig. 9) (Zhao et al., 2015).  
  
Fig. 9. Inhibitory effect of glutathione peroxidase 3 (GPX3) on Wnt  
and PI3K/Akt/c-fos signaling pathways Wnt pathway – intracellular 
signaling pathway, regulating embryonic development, differentiation 
and malignant development; PI3K/Akt/c-fos pathway – an intracellular 
signaling pathway regulating the cell cycle, c-fos – protoncogene  
It has been reliably established that for many cancers, such as can-
cer of the prostate, stomach, cervix, thyroid gland and colon, there is a 
decrease in GPX3 expression and hypermethylation. An experiment on 
mice with a GPX3 deletion in a colon tumour model reveals an increase 
in their number but not their size. In the same group of mice, an increase 
in the degree of dysplasia, an increase in proliferative activity, an in-
crease in the number of pro-tumour macrophages, and an increase in 
DNA damage are observed. At the same time, activity in the WNT 
signal transmission chain increases. In a model of Caco2 cells (human 
adenocarcinoma cells), GPX3 was knocked down, which led to an 
increase in oxidative stress, an increase in reactive oxygen species, 
DNA damage, and activation of apoptosis. Summing up, the authors 
define the function of GPX3 as immunomodulatory (Barrett et al., 2013).  
The genetic relationship between the expression of selenoproteins 
and the risk of breast cancer has been studied using polymorphisms in 
the genes SEPP1 (selenoprotein P), GPX1 (glutathione peroxidase 1), 
GPX4 (glutathione peroxidase 4) and antioxidant enzyme genes SOD2. 
The risk of breast cancer was reduced by 60% in women homozygous 
for SEPP1. At the same time, Leu carriers for GPX1 polymorphism had 
teratogenic risks two times higher. It was also found that the activity of 
GPX in red blood cells depends on the genotype, and this activity is 
lower in women with the development of breast cancer at a later age. 
The MCF7 cell model (invasive breast adenocarcinoma cells) also 
shows an increase in GPX1 levels when exposed to β-estradiol and 
sodium selenite (Méplan et al., 2013).  
A dual effect of glutathione peroxidase 2 (GPx2) on colon carcino-
genesis has been identified. On a GPx2 knockout mouse model and in 
the minimized, moderate, and increased selenium intake, treatment with 
an oncogen (azoxymethane) was performed. Interestingly, minimized 
and increased selenium intake in GPx2 knockout mice shows a signifi-
cant decrease in the number of tumours compared to the wild type. 
The authors suggest that GPx2 knockout initiates apoptotic death of 
damaged and precancerous cells, as the GPx2 is significantly increased 
and suppresses apoptosis of atypical cells in dysplastic crypts of wild-
type mice. In the intestinal mucosa with moderate consumption of sele-
nium, the number of tumours in both genotypic groups is the same, but 
the tumour size is larger in mice with knockdown, where an inflamma-
tory processes increase. Thus, the role of GPx2 as a modulator depends 
on the presence of the inflammatory process and the level of selenium 
consumption (Müller et al., 2013).  
The role of glutathione peroxidase 2 (GPX2) in humans and rats 
has been investigated in a castration-resistant prostate cancer model. 
It was revealed that deletion of GPX2 caused a significant suppression 
of growth and an increase in the number of reactive oxygen species in 
rat and human adenocarcinoma cells. According to the author, suppres-
sion of proliferation in knockout mice is associated with cyclin B1-
dependent G2/M blockade (Fig.10). Also knockdown of glutathione 
peroxidase 2 (GPX2) inhibits tumour growth. Immunohistochemistry 
reveals GPX2 expression is significantly higher in the focus of residual 
cancer after hormone therapy than in focus of cancer without it. Signifi-
cantly lower survival is observed in patients with high expression of 
GPX2 in biopsy than in patients with low expression or its complete 
absence. The authors conclude that GPX2 significantly affects the proli-
feration of prostate cancer through protection against signal transduction 
of reactive oxygen species and can act as a prognostic marker (Naiki et 
al., 2014) (Fig. 10).  
  
Fig. 10. Inhibition of proliferative processes  
by glutathione peroxidase 2 (GPX2) mediated by cyclin B1  
In some tumours, the glutathione peroxidase 3 (GPX3) gene is me-
thylated, which is studied in colorectal carcinoma using models of the 
primary tumour, cell lines, knockdown cell lines, and xenograft tumour 
cell lines. Methylation of the glutathione peroxidase 3 gene leads to a 
decrease in the expression of this enzyme and an increase in sensitivity 
to cisplatin. And conversely, increased expression or the ability to in-
crease expression reduces sensitivity to cisplatin. In the GPX3 knock-
down model of a cell line, survival of cells is not possible due to a redox 
balance violation. Methylation of the GPX3 promoter in the tumour 
xenograft model also reduces the expression of the enzyme and increas-
es sensitivity to cisplatin with reverse tumour development in the case 
of knockdown and continued growth in the case of the wild type (Pelo-
sof et al., 2017).  
Redox signaling regulates physiological self-renewal, proliferation, 
migration, and differentiation in the gastrointestinal epithelium by mo-
dulating Wnt/β-catenin and Notch signaling pathways mainly through 
NADPH oxidases (NOXs). The progression of inflammatory bowel di-
sease depends on the balance of pro-inflammatory redox-sensitive path-
ways, such as NLRP3 inflammation and NF-κB, and adaptive activa-
tion of Mn superoxide dismutase and glutathione peroxidase 2. In colo-
rectal cancer, redox signaling has two opposite sides: on the one hand, 
NOX1 activation and the H2O2 derivative enhance Wnt/β-catenin and 
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Notch proliferation pathways; on the other hand, reactive oxygen spe-
cies inhibit tumour progression through activation of apoptotic mechan-
isms (Pérez et al., 2017).  
Knockdown of glutathione peroxidase 4 gene in the mouse epi-
dermis leads to hyperplasia, inflammatory infiltrates in the dermis, and 
alopecia immediately after birth, however, after 5 weeks, the disorder 
disappears. In keratinocyte cell culture, the knockdown of GPx4 reduc-
es cell adhesion and increases lipid peroxidation and cyclooxygenase-2 
levels, which indicates the effect of GPx4 in the skin on the regulation 
of cyclooxygenase-2 morphogenesis (Sengupta et al., 2013).  
Overexpression of GPX2 is noted in the cell lines of UC, BC31, 
and RT4 bladder carcinoma. Deletion of GPX2 inhibits the formation of 
reactive oxygen species in these cells, inhibits their growth and activates 
apoptosis through stimulation of caspases 3 and 7 (Naiki et al., 2018).  
GPx3 directly interacts with the p53-induced gene, and overexpres-
sion of GPx3 in prostate cancer cell lines stimulates the death of apop-
totic cells, which was probably due to an increase in the number of 
reactive oxygen species and activation of caspase 3. It was also found 
that apoptosis due to ultraviolet light is mediated by signal transmission 
in the way of the GPx3 -p53 (Wang et al., 2012).  
Increased expression of Nrf-2 in glioma stem cells increases tran-
scription of GPx1 and reduces the formation of reactive oxygen species, 
which leads to radioresistance of glioma. MicroRNA (miR)-153, the 
gene of which is associated with Nrf-2, was suppressed with an increase 
in Nrf-2. And vice versa, overexpression of miRNA-153 miRNA re-
duced the ability of glioma stem cells to form neurospheres, stimulated 
differentiation through ROS-mediated activation of p38 MAPK. Thus, 
overexpression of miR-153 reduced the radioresistance and stemming of 
glioma cells by targeting the Nrf-2/GPx1/ROS pathway (Yang et al., 2015).  
Overexpression and knockdown of GPX4 are able to modulate the 
lethality of 12 inducers of ferroptosis. The most sensitive to GPX4-
regulated ferroptosis were renal cell carcinoma and B-cell lymphomas 
(Yang et al., 2014).  
The heat shock protein HSPA5 negatively affects ferroptosis in 
pancreatic duct carcinoma cell models. When transcription factor 4 is 
activated, HSPA5 expression is stimulated, which in turn leads to GPX4 
binding and protection against lipid peroxidation. Thus, the HSPA5-
GPX4 pathway targets resistance to ferroptosis (Zhu et al., 2017).  
Deletion of one or both GPx3 alleles leads to an increase in the inci-
dence of prostate cancer in a mouse model and is mediated by activa-
tion of the Wnt/β-catenin signaling pathway (Chang et al., 2016).  
 
Signaling paths mediated by diiodinases  
 
Iodothyronindeiodinases or simply deiodinases, enzymes contai-
ning selenocysteine, which refers them to the family of selenoproteins, 
catalyze the activation of T4 by converting it into T3, while the iodine 
atom is removed from the inner or outer ring of the hormone. Moreover, 
selenocysteine is located in the active centers of enzymes (Schweizer 
et al., 2014). Deiodinase 3 (DIO3) is significantly activated with papil-
lary thyroid carcinoma, with a direct correlation between an increase in 
DIO3 level and tumour size, metastasis. Using the model of thyroid 
papillary carcinoma cells (K1 and TPC-1), the signaling pathways in-
volved in DIO3 activation in this tumour are studied. Reduced DIO3 
expression in cells in K1 and TPC-1 specifically inhibits BRAF, MEK, 
or p38 oncogen signaling. siRNA-mediated deletion of DIO3 stimulates 
a decrease in the expression of cyclin D1 and a partial arrest of the cell 
cycle of the G1 phase, thereby inhibiting cell proliferation. At the same 
time, blocking the Hedgehog signaling pathway (SHH) leads to a sig-
nificant decrease in DIO3 mRNA. The authors indicate that activation 
of the MAPK and SHH signaling pathways alters the levels of DIO3 
expression in papillary thyroid carcinoma. Moreover, the deletion of 
DIO3 reduces the proliferation and growth of the tumour (Romitti et al., 
2016) (Fig. 11).  
 
Signaling pathways mediated by methionine sulfoxide reductase  
 
MsrA, which belongs to the class of thiol oxidoreductases contai-
ning catalytic cysteine (Cys) or selenocysteine (Sec)residues, mediates 
ubiquitination of the 14-3-3 zeta protein and promotes the binding of 
14-3-3 proteins to alpha synuclein in the brain. MsrA in mammals can 
compete for the capture of ubiquitin using the same active site that is 
contained for binding methionine sulfoxide and mice knocked out by 
MsrA have elevated levels of dopamine expression (Deng et al., 2018).  
  
Fig. 11. Inhibition of signaling translation BRAF, MEK,  
p38 oncogenes, and cyclin D1 expression by deiodinase 3  
DIO3 – deiodinase 3, a BRAF – protoncogene that influences normal  
cell growth and differentiation and participates in the MAPK/ERK  
signaling pathway; MEK – mitogen-activated protein kinase;  
p38 – protein kinase of the MAPK signaling pathway  
Selenoprotein methionine R-sulfoxide reductase B1 (MsrB1) con-
trols actin assembly along with Mical proteins through stereospecific 
oxidation and methionine reduction in a reversible, site-specific manner. 
MsrB1, an antagonist of the Mical protein, which converts two methio-
nine residues in actin into methionine-R-sulfoxide, reduces the last one 
to methionine, which ensures disassembly and assembly at the same 
time. Stimulation of the expression of MsrB1 by macrophages reveals 
before their activation (Gladyshev et al., 2014).  
The selenoprotein-containing methionine sulfoxide reductase Msr 
is studied in stellate cells of the pancreas. It was found that rat stellate 
pancreatic cells express MsrA, B1, B2, their expression is reduced in 
cell culture. Overexpression of these selenoproteins enhances ATP-de-
pendent increase in calcium, but at the same time reduces the formation 
of reactive oxygen species and the production of IL-1, which are caused 
by lipopolysaccharides. Overexpression of MsrA, B1 also suppresses 
the dominance of acinar cells over stellate cells during their joint cultiva-
tion, which indicates the important role of Msr in the development of 
stellate pancreatocytes (Liu & Cui, 2019).  
In vitro knockdown of methionine sulfoxide reductase B1 (MsrB1) 
inhibits hepatocellular carcinoma cell growth, while MsrB1 interference 
enhances apoptosis, which is caused by hydroperoxides. At the same 
time, silencing MsrB1 inhibits the phosphorylation of ERK, MEK, and 
p53 proteins (key players in the MAPK signaling pathway) while in-
creasing PARP and caspase 3, which causes mitochondrial damage. 
In vivo silencing of MsrB1 actively inhibits tumour growth. Moreover, 
knockdown reduces the migration and invasion of hepatocellular carcino-
ma cells by suppressing the epithelial-mesenchymal transition (EMT). 
Thus, the authors emphasize that MsrB1 regulates the proliferation and 
migration of hepatocellular carcinoma cells by modulating the pathways 
of MAPK and EMT (He et al., 2018) (Fig. 12).  
 
Fig. 12. Inhibition of protein phosphorylation of the MAPK signaling 
pathway and increase of PARP and caspase by methionine sulfoxide 
reductase B1 MsrB1 – methionine sulfoxide reductase B1;  
ERK – extracellular signal-regulating kinase; MEK – mitogen-activated 
extracellular kinase; p53 – protein involved in transcription and regula-
tion of the cell cycle; PARP – enzymes that regulate post translational 
modifications of proteins; a caspase3 – proteolytic enzyme whose  
activation is involved in cell apoptosis  
In a model of mice knocked out with the selenium-containing me-
thionine sulfoxide reductase MsrA gene, a study of the effect of the last 
one on inflammatory reactions induced by lipopolysaccharide (LPS) 
reveals a high susceptibility of mice to LPS-induced lethal shock. An in-
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crease in serum cytokines IL-6 and TNF-α was also noted. Initial and 
LPS-induced levels of reactive oxygen species were elevated, as were 
the levels of phosphorylation of p38, JNK, and ERK, indicating activa-
tion of MAPK. In addition, NF-κB expression (a transcription factor 
that controls the expression of immune response, apoptosis, and cell 
cycle genes) is increased. The authors suggest that MsrA deficiency ne-
gatively regulates pro-inflammatory responses by inhibiting ROS-
MAPK-NF-κB signaling pathways (Singh et al., 2017) (Fig. 13).  
 
Fig. 13. Inhibition of protein phosphorylation of the MAPK signaling 
pathway and increase of NF-κB by methionine sulfoxide reductase A 
ERK – extracellular signal-regulating kinase; MsrA – methionine  
sulfoxide reductase A; JNK – Jun N-terminal kinases, activator of apop-
totic signaling; p38 – protein kinase of the MAPK signaling pathway; 
NF-κB – transcription factor, regulator of expression of immune  
response genes, apoptosis and cellular response  
Fan et al. (2015) regards MsrA as a factor limiting uncontrolled 
neuroinflammation, since MsrA expression increased upon microglia 
activation. Under the influence of MsrA, inflammation is reduced, 
which was provoked by lipopolysaccharide (LPS). Inhibition of inflam-
mation occurs by inhibiting signaling pathways such as mitogen-activa-
ted p38 and ERK protein kinases (MAPKs) and nuclear factor kappaB 
(NF-κB). This confirms the direct involvement of MsrA in neuroin-
flammation mediated by microglia.  
Also Lee et al. (2017) in a mouse model determine that selenium-
containing MsrB1 exhibits increase expression in activated macropha-
ges and is thus involved in the body’s immune responses. It is noted that 
MsrB1 is activated by lipopolysaccharide (LPS), while the other enzy-
mes of the Msr family remain intact. Deletion of the MsrB1 gene does 
not interfere in macrophages with the functioning of the signaling path-
way that was started by LPS, but causes a decrease in the generation of 
anti-inflammatory cytokines such as interleukin (IL)-10 and the receptor 
antagonist IL-1. This is due to the fact the production of pro-inflamma-
tory cytokines increase significantly. It follows that MsrB1 controls 
immune responses by stimulating the expression of anti-inflammatory 
cytokines in macrophages.  
In the cell culture of the lens epithelium, the selenoprotein R knock-
down with the accompaniment of galactose-induced apoptosis show 
sstimulation of oxidative stress. The influence of galactose in the case of 
selenoprotein R knockdown leads to a more powerful rise in glucose-
regulated protein levels and decreases mitochondrial membrane potenti-
al due to the release of mitochondrial cytochrome. Simultaneously the 
number of apoptotic cells rises (Dai et al., 2016).  
The deficiency of MsrB3 (methionine sulfoxide reductase B3) faci-
litates tumour cells apoptosis by the mitochondrial pathway, which 
leads to destruction of tumour cells. ER stress causes these changes. 
The proapoptotic Bim molecule is activated by MsrB3 starvation and ini-
tiates ER-stress induced apoptosis. Cytosolic levels of Ca2+ are increased 
due to ER stress in the case of MsrB3 deletion (Kwak & Kim, 2017).  
In the model of cardiovascular diseases, the role and signaling path-
ways of methionine sulfoxide reductase A (MsrA), which is determined 
in all layers of the vascular wall of human arteries and mice, were de-
termined. The deletion of the MsrA gene in mice does not affect the 
area of experimental atherosclerotic damage and damage after thrombo-
sis, but after ligation of the carotid artery, the area of regeneration of 
damaged arteries is significantly larger in MsrA-deficient mice. Also, in 
the case of MsrA deficiency in aortic smooth muscle cells, proliferation 
accelerates due to the accelerated G1/S transition, and the generation 
and activity of the cyclin D1 protein and cdk4/cyclin D1 complex in-
crease, which in turn leads to increased phosphorylation of retinoblas-
toma protein and transcription E2F. MsrA deficient cells also show a 
significant increase in 1/2 kinase, indicating an increase in the activity of 
the Ras/Raf/mitogen-activated protein kinase signaling pathway (Klu-
tho et al., 2015).  
Methionine sulfoxide reductase B1 (MsrB1), being one of the en-
zymes that inactivate methionine sulfoxides, which are formed from 
reactive oxygen species, has been studied in some tumours. The knock-
down of this selenoprotein inhibits the proliferation of u2os cells (an 
osteosarcoma cell line) and also affects the pathway of mitogen-activa-
ted protein kinase (MAPK) by suppressing phosphorylation of Erk, 
MeK and p53 expression in u2os cells. In the case of a xenograft of a 
similar tumour in mice, knockdown B1 (MsrB1) perfectly inhibits the 
growth of the neoplasm, and also significantly reduces the migration 
and invasion of u2os cells. Also MsrB1 controls the epithelial-mesen-
chymal transition by affecting the cytoskeleton by increasing the ex-
pression of E-cadherin and decreasing N-TGF-β1, fibronectin, vimen-
tin, c-myc, and β-catenin. Thus, the authors emphasize that the MsrB1 
gene can serve as a target against tumours (Li et al., 2018).  
 
Signal pathways of selenoproteins without specific localization  
 
Knockdown of selenoprotein U in the testicle cells of the chicken 
model causes an increase in mRNA and expression of autophagy and 
antiapoptosis proteins while reducing antiautophagic (mTOR) and pro-
apoptotic proteins. Inactivation upon knockdown of selenoprotein in 
mTOR, which is a component of the signaling pathway that regulates 
basic cell processes, such as growth, proliferation, indicates the regula-
tory effect of this selenoprotein on such an important regulation me-
chanism. At the same time, knockdown of selenoprotein U causes a 
decrease in the activity and expression of such participants of the intra-
cellular signaling pathway as phosphoinositide-3-kinase (PI3K) and 
protein kinase B (PKB/Akt) both at the mRNA level and at the protein 
level (Sattar еt al., 2018) (Fig. 14).  
 
Fig. 14. Inhibition of PI3K and PKB signaling pathways  
by knockdown of selenoprotein U Sel U – selenoprotein U;  
PI3K – phosphoinositide-3-kinase; PKB – protein kinase  
Researchers suggest that in vivo use of apomorphine in lung adeno-
carcinoma prevents brain metastases by affecting the KIF16B (protein 
whose biological functions are associated with transport, alternative 
splicing), SEPW1 (selenoprotein W) and TESK2 associated with pre-
metastasis. Patients with poor survival have a low expression of these 
genes, which can affect the cellular and molecular dynamics of preme-
tastasis (Singh et al., 2018).  
In the chicken model, the inflammatory process and selenoprotein 
W were studied. Lymphoid tissue and cultivated spleen leucocytes were 
used for the study effects of selenoprotein W. Diet deficiency of sele-
nium impacts on and diminishes selenoprotein W mRNA expression, 
which in turn stimulates increase in parameters of COX-2 (cyclooxyge-
nase-2), iNOS (nitric oxide synthase), NF-κB (nuclear factor-kB), 
PTGE and TNF-α (tumour necrosis factor). Selenoprotein W deletion 
leads to damage to lymphoid tissue (Yu et al., 2015).  
In the model of lung lymphocytes with selenoprotein W deletion, 
which are exposed in H2O2, the impact on cell apoptosis, viability, and 
expression of mRNA of selenoprotein W is revealed. Deletion of sele-
noprotein W leads to diminishing of cell vitality, speeding of apoptosis 
and increases sensitivity to H2O2. The cell treatment with sodium sele-
nite strongly enhance selenoprotein W expression, and cell apoptosis 
caused by H2O2 decreases, cell vitality increases (Yu et al., 2014).  
One of the less studied selenoproteins O impacts on chondrocyte 
differentiation: it is revealed mRNA and selenoprotein O rise during 
chondrogenic induction of ATDC5 cells. Knockdown of selenoprotein 
O leads to a reduction of chondrogenic differentiation accompanied by 
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some cartilaginous glycosaminoglycans cumulation and a decrease of 
alkaline phosphatase activity in cells with Selene deficiency. The sup-
pression of proliferation is caused by cell cycle progression delay. Dele-
tion of selenoprotein O induces chondrocytes death by apoptosis (Yan 
et al., 2016).  
 
Conclusions  
 
The participation of selenoproteins in many signaling pathways 
confirms their modulating role in many pathogenetic processes. When 
analyzing the authors’ data, the following molecular signaling pathways 
in which the influence of selenoproteins are involved are distinguished:  
– PI3K/Akt/Erk;  
– PI3K/Akt/mTOR – main signaling intracellular pathway, provid-
ing growth, cell proliferation, metabolism and avoidance of apoptosis;  
– PI3K/Akt/c-fos – pathway responsible for growth, proliferation, 
avoidance of apoptosis;  
– IRE1α – sXBP1 – pJNK – the first participant in the signaling path-
way changes gene expression during stress of the endoplasmic reticulum; 
the second is a transcription factor that regulates the expression of genes 
important for the proper functioning of the immune system and the cellu-
lar response to stress; and the third activate apoptotic signaling;  
– NF-κB transcription factor controlling the expression of the im-
mune response, apoptosis, and cell cycle genes;  
– TGF-β-Akt / GSK-3β;  
– Wnt/β-catenin – intracellular signaling method, regulating em-
bryonic development;  
– MAPK;  
– PKB/Akt.  
For example, some of them are closely related to the regulation of 
Ca2+ flux both inside the cell and across the membrane of the endop-
lasmic reticulum. Modulation of the Ca2+ flow is the basis of such pa-
thological processes as myopathy, carcinogenesis.  
Changes in the Ca2+ flow through the endoplasmic reticulum can 
be modulated by SelN and SelK, the activity of the last one being asso-
ciated with the inositol triphosphate receptor (IP3R), which is the Ca2+ 
channel. The impact on this molecular pathway is carried out indirectly 
through special proteins (DHHC6, CHERP).  
Signaling pathways that regulate many basic functions such as 
growth, cell proliferation, metabolism, initiation of apoptosis, and res-
ponse to stress are interrelated with selenoproteins. So SelS modulates 
the signaling pathway IRE1α – sXBP1 – pJNK, SelМ is connected with 
the signaling path PI3K/Akt/mTOR. SelP, which has a special apoER2 
receptor in the endoplasmic membrane, also influences the 
PI3K/Akt/Erk signaling pathway.  
Thioredoxin reductases 1 and 2, cytosolic and mitochondrial, res-
pectively, are noted in the regulation of such intracellular promoters as 
ASK1 – kinase, Prx3 – peroxyredoxine 3, Msrs – methioninsulfoxido-
reductase, and mTOR – protein-kinase important mechanisms and, 
therefore, are active in molecular mechanisms.  
Three isoforms of glutathione peroxidase are promoters of some 
signaling pathways, of which GPX3 is related to the PI3K/Akt/c-fos 
and Wnt/β-catenin signaling pathways, GPX1 and GPX4 are associated 
with the NF-κB caspase signaling pathway, and GPX2 realizes its effect 
through cyclin B1 per cell cycle.  
Among the isoforms of deiodinases, deiodinase 3 (DIO3), which is 
associated with the MAPK and SHH signaling pathways, is mentioned; 
activation of the latter one leads to a change in the expression levels of 
this selenoprotein. Methionine sulfoxide reductases are also intercon-
nected with some signaling pathways.  
In addition to the above signaling pathways, many selenoproteins 
directly affect other regulatory proteins, such as p53, which is a suppres-
sor of the formation of malignant tumours (SelH), oxidoreductin, p 38, 
proteinkinase of the MAPK signaling pathway.  
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